A year after becoming available, vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, according to a new health survey.
Source link
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.